Refresh

Jubilant Pharmova Ltd. - Research Center

530019 JUBLPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Sales

810.12 87.75 2,709.50 3,139.90 3,438.61

Operating profit

3.22 -6.78 427.06 370.91 320.87

Interest

18.52 30.59 101.80 136.20 128.96

Gross profit

122.59 88.50 373.14 407.94 269.91

EPS (Rs)

3.13 4.93 13.46 20.16 9.27
Annual  results in details
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19

Other income

137.89 125.87 47.88 173.23 78.00

Stock adjustment

3.45 - 55.21 -108.32 46.74

Raw material

396.30 - 1,328.92 1,683.29 1,874.60

Power and fuel

- - 280.40 369.20 358.28

Employee expenses

167.27 49.21 220.67 264.90 265.71

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

239.88 45.32 397.24 559.92 572.41

Provisions made

- - - - -

Depreciation

43.25 6.25 99.97 107.40 86.48

Taxation

29.46 3.75 58.69 -22.30 35.80

Net profit / loss

49.88 78.50 214.48 321.14 147.63

Extra ordinary item

- - - -1.70 -

Prior year adjustments

- - - - -

Equity capital

15.93 15.93 15.93 15.93 15.93

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

0.40 -7.73 15.76 11.81 9.33

GPM (%)

12.93 41.43 13.53 12.31 7.68

NPM (%)

5.26 36.75 7.78 9.69 4.20
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com